Funding secured for the CapFuran® toxicity study
We are pleased to announce that our CSO, Dr Jenny Rohn, recently secured funding as the principal investigator on a competitive grant from UCL Innovation & Enterprise, in the Discovery-to-use scheme.
News and press releases about AtoCap, our work
and our clinical development.
AtoCap patent granted in the United States
AtoCap is delighted to announce the US grant of its core patent on novel micro- and nanoencapsulation technology. This constitutes a significant milestone in the company’s development.
CapFuran® preclinical study published in the Journal of Controlled Release
This research was carried out as a vibrant, interdisciplinary collaboration between the respective laboratory teams of Jennifer Rohn (CSO) and those of two of AtoCap’s founders, Mohan Edirisinghe and Eleanor Stride.
Cristina Diaz joins the AtoCap Board
We are delighted to welcome Cristina Diaz into the AtoCap family as our most recent Board member.
AtoCap Chief Scientific Officer Jennifer Rohn's opinion sought on coronavirus
While treatment of urinary tract infections remains the lead clinical application for the AtoCap encapsulation technology, our new CSO's expertise extends far beyond this.
AtoCap team visits GMP manufacturing facility in Valencia
Just before Christmas, Ann Savell, Eleanor Stride and Jenny Rohn inspected Bioinicia's Electrospraying Assisted by Pressurized Gas (EAPG) industrial demonstration facility in Valencia.
AtoCap © copyright 2022
- Contact Us
- Privacy Policy
- Site by Liquorice